Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Dec;25(12):1521-6.
doi: 10.1023/a:1026620316090.

G proteins modulate D2 receptor-coupled K(ATP) channels in rat dopaminergic terminals

Affiliations

G proteins modulate D2 receptor-coupled K(ATP) channels in rat dopaminergic terminals

C Neusch et al. Neurochem Res. 2000 Dec.

Abstract

The presynaptic dopamine (DA) D2 receptor-mediated regulation of ATP-sensitive potassium (K+ATP) channels was examined in slices of the rat caudate-putamen. When slices were incubated with the specific D2 receptor antagonist (-)-sulpiride (SLP), a concentration-dependent increase of extracellular DA release was observed. SLP-induced enhancement was completely antagonized by coincubation with the K+ATP channel opener diazoxide (DIA). Treatment of slices with the D2 receptor agonist quinpirole (QUI) almost completely inhibited DA outflow induced by the K+ATP channel blocker butanedione-monoxime (BDM). Coincubation of SLP and guanosine triphosphate (GTP) or its non-hydrolizable analogue guanylyl-5'-imidodiphosphate [Gpp(NH)p], significantly reduced the SLP-induced effect on DA levels. Furthermore, we observed that BDM-induced DA outflow was markedly inhibited by G protein activators suggesting an additional receptor-independent regulation of K+ATP channel gating. Our results suggest that PTX-sensitive G proteins are involved in the signal transduction between D2 receptors and K+ATP channels. Furthermore, K+ATP channels can be modulated in a receptor-independent mechanism by G protein activators.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neuroreport. 1995 Jun 19;6(9):1277-80 - PubMed
    1. Neurochem Int. 1997 Aug;31(2):307-11 - PubMed
    1. Eur J Pharmacol. 1996 Feb 15;297(1-2):35-41 - PubMed
    1. Mol Pharmacol. 1993 Nov;44(5):907-10 - PubMed
    1. Neurochem Int. 1996 Jan;28(1):109-12 - PubMed

LinkOut - more resources